Wednesday, 5 Jan 2011 07:00pm EST
Kangmei Pharmaceutical Co., Ltd. announced that (600518.SH)it has completed its rights issue, with 504,344,431 A shares of common stock purchased at RMB 6.88 per share, raised RMB 3,469,889,685.28. The Company's shareholders were eligible to purchase three shares for every ten shares they hold.
 

Source:Reuters